Abbott Labs Plans $10 Bln Bond Sale (Fox News)

Part of proceeds would fund company’s spin-off of pharmaceuticals unit.

Abbott Laboratories plans to sell more than $10 billion of fixed-income securities this week, according to Fox News, as it prepares to spin off its pharmaceutical operations into a new company, AbbVie. 

Abbott announced Friday that it was offering to buy back up to $7.7 billion in nine outstanding debt issues that mature between 2014 and 2040. It said that its subsidiary, AbbVie, will sell debt and use the proceeds to pay Abbott a dividend.  


See the full story here.


Advertisement. Closing in 15 seconds.